USD
$0.00
(0.00%
)At Close (As of Oct 13, 2025)
$57.24M
Market Cap
45
P/E Ratio
0.12
EPS
$5.97
52 Week High
$1.36
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $8.7M |
Total Revenue | $14M |
Cost Of Revenue | $5.4M |
Costof Goods And Services Sold | $5.4M |
Operating Income | $6K |
Selling General And Administrative | $7.7M |
Research And Development | $906K |
Operating Expenses | $8.7M |
Investment Income Net | - |
Net Interest Income | $93K |
Interest Income | $94K |
Interest Expense | $1K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $137K |
Income Before Tax | $89K |
Income Tax Expense | $15K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $74K |
Comprehensive Income Net Of Tax | - |
Ebit | $90K |
Ebitda | $227K |
Net Income | $74K |
Field | Value (USD) |
---|---|
Total Assets | $11M |
Total Current Assets | $8.3M |
Cash And Cash Equivalents At Carrying Value | $3.8M |
Cash And Short Term Investments | $3.8M |
Inventory | $2.6M |
Current Net Receivables | $1.8M |
Total Non Current Assets | $2.9M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $565K |
Intangible Assets Excluding Goodwill | $565K |
Goodwill | $759K |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $142K |
Other Non Current Assets | - |
Total Liabilities | $2.6M |
Total Current Liabilities | $1.6M |
Current Accounts Payable | $649K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $348K |
Total Non Current Liabilities | $1.1M |
Capital Lease Obligations | $1.4M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.4M |
Other Current Liabilities | $521K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $8.6M |
Treasury Stock | - |
Retained Earnings | -$144M |
Common Stock | $11K |
Common Stock Shares Outstanding | $11M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$492K |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $137K |
Capital Expenditures | $55K |
Change In Receivables | - |
Change In Inventory | -$407K |
Profit Loss | - |
Cashflow From Investment | -$50K |
Cashflow From Financing | -$5K |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $74K |
Field | Value (USD) |
---|---|
Gross Profit | $8.7M |
Total Revenue | $14M |
Cost Of Revenue | $5.4M |
Costof Goods And Services Sold | $5.4M |
Operating Income | $6K |
Selling General And Administrative | $7.7M |
Research And Development | $906K |
Operating Expenses | $8.7M |
Investment Income Net | - |
Net Interest Income | $93K |
Interest Income | $94K |
Interest Expense | $1K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $137K |
Income Before Tax | $89K |
Income Tax Expense | $15K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $74K |
Comprehensive Income Net Of Tax | - |
Ebit | $90K |
Ebitda | $227K |
Net Income | $74K |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Nephros, Inc. is a commercial-stage medical technology company based in South Orange, New Jersey, specializing in innovative water purification solutions for the healthcare and commercial sectors. With a focus on improving patient outcomes and enhancing water quality in medical settings, Nephros offers a range of products designed to meet the stringent demands of clinical environments. The company's unique filtration technology not only addresses regulatory standards but also promotes operational efficiencies, positioning Nephros as a key player in the growing market for healthcare water solutions.